References
1. Cox MJ, Loman N, Bogaert D, O’Grady J. Co-infections: potentially
lethal and unexplored in COVID-19. Lancet Microbe. 2020;1(1):e11.
2. Ozaras R, Dilek A, Sunbul M, Leblebicioglu H. Association between
Crimean–Congo hemorrhagic fever (CCHF) and coronavirus disease 2019
(COVID-19): A systematic review. Infection Control & Hospital
Epidemiology. 2021:1-5.
3. Butt MH, Ahmad A, Misbah S, Mallhi TH, Khan YH. Crimean-Congo
hemorrhagic fever and Eid-Ul-Adha: A potential threat during the
COVID-19 pandemic. J Med Virol. 2021;93(2):618-9.
4. Büyüktuna S, HASBEK M, ÖKSÜZ C, BAYSAL C, ÖZ M, ELALDI N, et al.
Kırım Kongo Kanamalı Ateşi Hastasında COVID-19 Ko-enfeksiyonu: Bir Olgu
Sunumu. Mikrobiyol Bul. 2021;55(3):445-51.
5. Dulger AC, Yakarisik M, Uzun YE, Sahin AM. Treatment of Crimean-Congo
Haemorrhagic Fever by Favipiravir in a Patient with Novel Coronavirus
Co-Infection. Eur J Case Rep Intern Med. 2020;7(12):002042.
6. Pazarli AC, Parlak Z, Ekiz T. COVID-19 and Crimean-Congo Hemorrhagic
Fever: Similarities and Differences. Heart Lung. 2020;49(6):892-3.
7. Ahmadkhani M, Alesheikh AA, Khakifirouz S, Salehi-Vaziri M.
Space-time epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in
Iran. Ticks Tick Borne Dis. 2018;9(2):207-16.
8. Kassari H, Dehghani R, Kasiri M, Dehghani M, Kasiri R. A review on
the reappearance of Crimean-Congo hemorrhagic fever, a tick-borne
nairovirus. Entomology and Applied Science Letters. 2020;7(1):81-90.
9. Shayan S, Bokaean M, Shahrivar MR, Chinikar S. Crimean-Congo
hemorrhagic fever. Laboratory medicine. 2015;46(3):180-9.
10. Greene L, Uwishema O, Nicholas A, Kapoor A, Berjaoui C, Adamolekun
E, et al. Crimean-Congo haemorrhagic fever during the COVID-19 pandemic
in Africa: efforts, recommendations and challenges at hand. African
Journal of Emergency Medicine. 2022;12(2):117-20.
11. Osquee HO, Pourjafar H, Taghizadeh S, Haghdoost M, Ansari F.
Laboratory features of 160 CCHF confirmed cases in Zabol of Iran: A
10-year study. Journal of Infection. 2017;74(4):418-20.
12. Lippi G, Plebani M. Laboratory abnormalities in patients with
COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131-4.
13. Sas MA, Vina-Rodriguez A, Mertens M, Eiden M, Emmerich P,
Chaintoutis SC, et al. A one-step multiplex real-time RT-PCR for the
universal detection of all currently known CCHFV genotypes. Journal of
virological methods. 2018;255:38-43.
14. Afshar ZM, Ebrahimpour S, Javanian M, Vasigala VR, Masrour-Roudsari
J, Babazadeh A. Vital role of chest CT in diagnosis of coronavirus
disease 2019 (COVID-19). Caspian journal of internal medicine.
2020;11(3):244.
15. Doganci L, Ceyhan M, Tasdeler NF, Sarikayalar H, Tulek N. Crimean
Congo hemorrhagic fever and diffuse alveolar haemorrhage. Trop Doct.
2008;38(4):252-4.
16. Löffler C, Mahrhold J, Fogarassy P, Beyer M, Hellmich B. Two
immunocompromised patients with diffuse alveolar hemorrhage as a
complication of severe coronavirus disease 2019. Chest.
2020;158(5):e215-e9.
17. Yapar D, Akdoğan Ö, Boyacı H, Yılmaz YA, Topçu H, Arslan S, et al.
COVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in
Chest Radiology? Infectious Diseases and Clinical Microbiology.
2022;4(1):1-7.
18. Dogan OT, Engin A, Salk I, Epozturk K, Eren SH, Elaldi N, et al.
Evaluation of respiratory findings in Crimean-Congo hemorrhagic fever.
Southeast Asian J Trop Med Public Health. 2011;42(5):1100-5.
19. Aktas T, Aktas F, Ozmen Z, Altunkas A, Kaya T, Demir O. Thorax CT
findings in patients with Crimean-Congo hemorrhagic fever (CCHF).
Springerplus. 2016;5(1):1823.
20. Ture Z, Kalin-Unuvar G. A case of Crimean Congo hemorrhagic fever
complicated with acute pulmonary embolism. J Med Virol.
2021;93(6):3925-8.
21. Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri
SR, et al. SARS-CoV-2-related and Covid-19 vaccine-induced
thromboembolic events: A comparative review. Rev Med Virol.
2022;32(4):e2327.
22. Shirvani M, Janbakhsh A, Mansouri F, Sayad B, Vaziri S, Afsharian M,
et al. The Spectrum of Chest CT-Scans in the Hospitalized Patients with
the Coronavirus Disease. Journal of Kermanshah University of Medical
Sciences. 2020;24(4).
23. FEVER C-CH. Ribavirin: an effective treatment of Crimean-Congo
haemorrhagic fever. Pak J Med Sci July-September. 2004;20(3):201-6.
24. Afshar ZM, Babazadeh A, Javanian M, Barary M, Rekha VVK, Ebrahimpour
S. A comprehensive review of COVID-19 treatment. Acta facultatis medicae
Naissensis. 2021;38(2):105-15.
25. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I,
et al. Case management and supportive treatment for patients with
Crimean-Congo hemorrhagic fever. Vector-Borne and Zoonotic Diseases.
2012;12(9):805-11.
26. Cevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, et al.
Clinical and laboratory features of Crimean-Congo hemorrhagic fever:
predictors of fatality. Int J Infect Dis. 2008;12(4):374-9.
27. Spychalski P, Blazynska-Spychalska A, Kobiela J. Estimating case
fatality rates of COVID-19. Lancet Infect Dis. 2020;20(7):774-5.